PIDILITIND
vs
O
OMN
PIDILITIND
Over the past 12 months, PIDILITIND has underperformed OMN, delivering a return of -6% compared to the OMN's +8% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
PIDILITIND
See Who Stands Out.